DEA schedule
Is insulin aspart a controlled substance?
Federal schedule for insulin aspart from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Insulin aspart is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and insulin aspart is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted insulin aspart?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 35 prescription listings from 8 labelers, none with a DEA schedule |
| DEA controlled substances list | insulin aspart is not on the list |
Insulin Aspart NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 50090-4959 | .Insulin Aspart Protamine and Insulin Aspart | injection, suspension | 100 [iU]/mL | A-S Medication Solutions | None |
| 0169-3201 | Fiasp | injection, solution | 100 [iU]/mL | Novo Nordisk | None |
| 0169-3204 | Fiasp | injection, solution | 100 [iU]/mL | Novo Nordisk | None |
| 0169-3205 | Fiasp | injection, solution | 100 [iU]/mL | Novo Nordisk | None |
| 0169-3206 | Fiasp | injection, solution | 100 [iU]/mL | Novo Nordisk | None |
| 71288-903 | Garzulys | injection, solution | 100 [iU]/mL | Meitheal Pharmaceuticals Inc. | None |
| 71288-904 | Garzulys | injection, solution | 100 [iU]/mL | Meitheal Pharmaceuticals Inc. | None |
| 50090-4955 | Insulin Aspart | injection, solution | 100 [iU]/mL | A-S Medication Solutions | None |
| 50090-4956 | Insulin Aspart | injection, solution | 100 [iU]/mL | A-S Medication Solutions | None |
| 70518-3865 | Insulin Aspart | injection, solution | 100 [iU]/mL | REMEDYREPACK INC. | None |
| 73070-100 | Insulin Aspart | injection, solution | 100 [iU]/mL | Novo Nordisk Pharma, Inc. | None |
| 73070-102 | Insulin Aspart | injection, solution | 100 [iU]/mL | Novo Nordisk Pharma, Inc. | None |
| 73070-103 | Insulin Aspart | injection, solution | 100 [iU]/mL | Novo Nordisk Pharma, Inc. | None |
| 70518-3236 | Insulin Aspart Protamine and Insulin Aspart Mix 70/30 | injection, suspension | 100 [iU]/mL | REMEDYREPACK INC. | None |
| 73070-200 | Insulin Aspart Protamine and Insulin Aspart Mix 70/30 | injection, suspension | 100 [iU]/mL | Novo Nordisk Pharma, Inc. | None |
| 73070-203 | Insulin Aspart Protamine and Insulin Aspart Mix 70/30 | injection, suspension | 100 [iU]/mL | Novo Nordisk Pharma, Inc. | None |
| 83257-007 | KIRSTY | injection, solution | 100 [iU]/mL | Biocon Biologics Inc. | None |
| 83257-008 | KIRSTY | injection, solution | 100 [iU]/mL | Biocon Biologics Inc. | None |
| 0024-5927 | MERILOG | injection, solution | 100 [iU]/mL | Sanofi-Aventis U.S. LLC | None |
| 0024-5928 | MERILOG | injection, solution | 100 [iU]/mL | Sanofi-Aventis U.S. LLC | None |
| 0169-2100 | NOVOLOG | injection, solution | 100 [iU]/mL | Novo Nordisk | None |
| 0169-2101 | NOVOLOG | injection, solution | 100 [iU]/mL | Novo Nordisk | None |
| 0169-3303 | NOVOLOG | injection, solution | 100 [iU]/mL | Novo Nordisk | None |
| 0169-6338 | NOVOLOG | injection, solution | 100 [iU]/mL | Novo Nordisk | None |
| 0169-6339 | NOVOLOG | injection, solution | 100 [iU]/mL | Novo Nordisk | None |
| 0169-7501 | NOVOLOG | injection, solution | 100 [iU]/mL | Novo Nordisk | None |
| 50090-1664 | NOVOLOG | injection, solution | 100 [iU]/mL | A-S Medication Solutions | None |
| 50090-1678 | NOVOLOG | injection, solution | 100 [iU]/mL | A-S Medication Solutions | None |
| 50090-4500 | NOVOLOG | injection, solution | 100 [iU]/mL | A-S Medication Solutions | None |
| 0169-2200 | NovoLog Mix 70/30 | injection, suspension | 100 [iU]/mL | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-2201 | NovoLog Mix 70/30 | injection, suspension | 100 [iU]/mL | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-3685 | NovoLog Mix 70/30 | injection, suspension | 100 [iU]/mL | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-3696 | NovoLog Mix 70/30 | injection, suspension | 100 [iU]/mL | Novo Nordisk Pharmaceutical Industries, LP | None |
| 50090-2272 | NovoLog Mix 70/30 | injection, suspension | 100 [iU]/mL | A-S Medication Solutions | None |
| 70518-2119 | NovoLog Mix 70/30 | injection, suspension | 100 [iU]/mL | REMEDYREPACK INC. | None |
Questions
Is insulin aspart a controlled substance?
No. Insulin aspart is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and insulin aspart is not on the DEA controlled substances list.
Is insulin aspart a narcotic?
No. Insulin aspart is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Insulin Analog.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Insulin Aspart
- What is Novolog used for?FDA label uses
- Is Novolog a controlled substance?Federal schedule
- What is Fiasp used for?FDA label uses
- Is Fiasp a controlled substance?Federal schedule
- What is NovoLog Mix 70/30 used for?FDA label uses
- Is NovoLog Mix 70/30 a controlled substance?Federal schedule
- Insulin Analogs listFDA drug class
- Insulin Aspart Medicare Part D coverageBy plan and state
- NDC 0024-5927Insulin Aspart NDC record
- NDC 0024-5928Insulin Aspart NDC record
- NDC 0169-2100Insulin Aspart NDC record